EP1259512 - Bibliographic data
PTERIDINE COMPOUNDS FOR THE TREATMENT OF PSORIASIS
| Last update | 13/07/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Euro-PCT |
| (73) Holder |
ASTRAZENECA AB 15185 s
SÖDERTÄLJE
Suède
|
|---|---|
| (72) Inventors |
Bonnert, Roger AstraZeneca R & D Charnwood Bakewell Road
Loughborough Leics. LE11 5RH
Royaume-Uni
Gardiner, Stewart 3 Mayfield Leavenheath
Colchester Suffolk CO6 4US
Royaume-Uni
Hunt, Fraser AstraZeneca R & D Charnwood Bakewell Road
Loughborough Leics. LE11 5RH
Royaume-Uni
Walters, Iain AstraZeneca R & D Charnwood Bakewell Road
Loughborough Leics. LE11 5RH
Royaume-Uni
|
| (74) Agent |
Mail recipient PHILLIPS, NEIL GODFREY ALASDAIR AstraZeneca AB, Global Intellectual Property
151 85 Sodertalje
Suède
|
| (21) Request number | EP01906493.0 |
|---|---|
| (22) Request date | 20/02/2001 |
| (11) Publication number | EP1259512 |
|---|---|
| Publication date | 24/09/2003 |
| (54) Title of the invention | PTERIDINE COMPOUNDS FOR THE TREATMENT OF PSORIASIS |
|---|---|
| (51) International classification | None |
| International classification (before reform) | , , |
| Claimed priority |
(31) Number: 0004128 |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 12 -
Amount: 195 € -
Due date 29/02/2012
Surtax: 12 - Amount: 39 € - Due date 30/08/2012 |
|---|---|
| Last annuity | Annuity: 11 - Payment date 26/01/2011 |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2003/3, of 30/09/2003 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 24/09/2003 Déchéance du brevet d'invention après période de grâce - Legal date 29/02/2012 Entrée en période de grâce du brevet d'invention - Legal date 29/02/2012 |